General practical survey of individual prostate cancer screening
2008 - Guy L,Van-De-Steene E,Vedrine N,Teissonniere M,Boiteux JP Prog Urol n°18 - pp 46-52
GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease
2008 - Combes P,Henneke M,Diekmann S,Bertini E,Brockmann K,Burlina AP,Kaiser J,Ohlenbusch A,Plecko B,Rodriguez D,Boespflug-Tanguy O,Gartner J J Neurology n°70 - pp 748-54
High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system
2008 - Hanna WM,Hammond E,Taylor CR,Dabbs DJ,Penault-Llorca F,Bloom KJ,Bilous M,Badve S Mod Pathol n°21 - pp 1278-80
HPLC analysis of trans-reveratrol in human plasma after red wine consumption
2008 - Le-Corre L,Leger-Enreille A,Chalabi N,Delort L,Bignon YJ,Bernard-Gallon DJ The Open Chemical and Biomedical Methods Journal n°1 - pp 7-10
Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions
2008 - Macgrogan G,Arnould L,De-Mascarel I,Vincent-Salomon A,Penault-Llorca F,Lacroix-Triki M,Bibeau F,Baranzelli MC,Fridman V,Antoine M,Becette V,Brouste V,Jacquemier J,Mathoulin-Pelissier S Histopathology n°52 - pp 689-97
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab
2008 - Lievre A,Bachet JB,Boige V,Cayre A,Le-Corre D,Buc E,Ychou M,Bouche O,Landi B,Louvet C,Andre T,Bibeau F,Diebold MD,Rougier P,Ducreux M,Tomasic G,Emile JF,Penault-Llorca F,Laurent-Puig P J Clin Oncol n°26 - pp 374-79
Larsen-like phenotype associated with partial trisomy 3p and monosomy 5p
2008 - Goumy C,Beaufrere AM,Tchirkov A,Gouas L,Gaspard F,Giollant M,Roucaute T,Veronese L,Lemery D,Vago P Prenat Diagn n°28 - pp 131-4
Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma
2008 - Jarde T,Caldefie-Chezet F,Damez M,Mishellany F,Penault-Llorca F,Guillot J,Vasson MP Oncol Rep n°19 - pp 905-11
Low MCL-1 mRNA expression correlates with prolonged survival in B-cell chronoc lymphocytic leukemia
2008 - Veronese L,Tournilhac O,Verrelle P,Davi F,Dighiero G,Chautard E,Veyrat-Masson R,Kwiatkowski F,Goumy C,Vago P,Travade P,Tchirkov A Leukemia n°22 - pp 1291-3
Maternal serum screening in cases of mosaic and translocation Down syndrome
2008 - Dreux S,Olivier C,Dupont JM,Leporrier N,Oury JF,Muller F Prenat Diagn n°28 - pp 699-703
Measurement of residual disease after neoadjuvant chemotherapy
2008 - Abrial C,Thivat E,Tacca O,Durando X,Mouret-Reynier MA,Gimbergues P,Penault-Llorca F,Chollet P J Clin Oncol n°26 - pp 3094
Methionine dependency of cancer cells: a new therapeutic approach?
2008 - Durando X,Thivat E,Gimbergues P,Cellarier E,Abrial C,Dib M,Tacca O,Chollet P Bull Cancer n°95 - pp 69-76
Nutrigenomics and antioxidants (review)
2008 - Chalabi N,Bernard-Gallon DJ,Vasson MP,Bignon YJ Pers Med n°5 - pp 25-36
Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial
2008 - Durando X,Thivat E,Farges MC,Cellarier E,D-Incan M,Demidem A,Vasson MP,Barthomeuf C,Chollet P Nutr Cancer n°60 - pp 23-30
Orally administered isoflavones are present as glucuronides in the human prostate
2008 - Guy L,Vedrine N,Urpi-Sarda M,Gil-Izquierdo A,Al-Maharik N,Boiteux JP,Scalbert A,Remesy C,Botting NP,Manach C Nutr Cancer n°60 - pp 461-8
Ovarian epithelial dysplasia: myth or reality?
2008 - Chene G,Penault-Llorca F,Le-Bouedec G,Mishellany F,Dauplat MM,Tardieu AS,Pomel C,Jaffeux P,Aublet-Cuvelier B,Pouly JL,Dechelotte P,Dauplat J Gynecol Obstet Fertil n°36 - pp 800-7
p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes
2008 - Bidard FC,Matthieu MC,Chollet P,Raoelfils I,Abrial C,Domont J,Spielmann M,Delaloge S,Andre F,Penault-Llorca F Ann Oncol n°19 - pp 1261-5
Peritoneal mesothelioma: long survival with intraperitoneal chemotherapy, lanreotide and mucolytics
2008 - Montmayeur G,Thivat E,Gimbergues P,Dib M,LeHeurteur M,Cure H,Chollet P,Durando X Gastroenterol Clin Biol n°32 - pp 874-6
Place of anatomopathology in evaluation of response to neoadjuvant chemotherapy. Prognostic and predictive markers: example of breast cancer
2008 - Abrial C,Bouchet-Mishellany F,Raoelfils I,Cayre A,Cure H,Chollet P,Penault-Llorca F Lett Senol n°39 - pp 25-9
PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations
2008 - Bonnet-Dupeyron MN,Combes P,Santander P,Cailloux F,Boespflug-Tanguy O,Vaurs-Barriere C Hum Mutat n°29 - pp 1028-1036